NASDAQ · Medical Instruments & Supplies · USD
DENTSPLY SIRONA Inc. (XRAY) Stock Analysis
DENTSPLY SIRONA Inc. (XRAY) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
XRAY Key Statistics
As of Sep 4, 2026Trading
- Open
- $11.29
- Previous Close
- $11.43
- Day's Range
- 11.20–11.53
- 52-Week Range
- 9.41–14.76
- Volume
- 2.60M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.85
Valuation
- Market Cap
- $2.27B
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 7.50
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.74
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.62
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −2.73
Financials (FY)
- Revenue (FY)
- $3.68B−2.98%
- Net Income (FY)
- −$598.00M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −14.99%
- Shares Outstanding
- 199.35M
- 1-Year Return
- −18.38%
Dividend and dates
- Ex-Dividend Date
- December 26, 2025
- Earnings Date
- November 5, 2026estimated
- Avg Volume
- 5.05M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
XRAY Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −0.44% |
| 2025 | −36.84% |
| 2024 | −45.28% |
| 2023 | +13.50% |
| 2022 | −42.11% |
| 2021 | +7.32% |
| 2020 | −6.59% |
| 2019 | +53.14% |
| 2018 | −43.00% |
| 2017 | +14.67% |
| 2016 (partial year) | −4.96% |
As of September 4, 2026.
XRAY Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $3.68B | −$598.00M | −16.3% |
| 2024 | $3.79B | −$910.00M | −24.0% |
| 2023 | $3.97B | −$132.00M | −3.3% |
| 2022 | $3.92B | −$950.00M | −24.2% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $3.68B | $1.84B | $252.00M | −$598.00M | −16.3% |
| 2024 | $3.79B | $1.96B | $188.00M | −$910.00M | −24.0% |
| 2023 | $3.97B | $2.09B | $289.00M | −$132.00M | −3.3% |
| 2022 | $3.92B | $2.13B | $364.00M | −$950.00M | −24.2% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
XRAY Valuation vs Medical Instruments & Supplies Median
Median of 55 stocks| Metric | XRAY | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/S ratio | 0.62 | 3.17 | 0.2x the median |
| Profit margin | −14.99% | 0.85% | 15.8 pts below |
Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation
YahooDentsply Sirona (XRAY) Stock May Still Trade At A Discount
YahooDoes XRAY’s Profit Recovery and Reaffirmed 2026 Outlook Shift the Dentsply Sirona Thesis?
YahooDentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
YahooDentsply Sirona (XRAY) Swings Back To Profit While Sales Keep Sliding
YahooBarclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11
Benzinga
All 20 articles ↓Show fewer ↑
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call
YahooDentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript
YahooXRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds
YahooWhy Dentsply Sirona (XRAY) Stock Is Trading Lower Today
YahooDENTSPLY SIRONA Q2 Earnings Call Highlights
Yahoo1% Undervalued? DENTSPLY SIRONA (XRAY) As Earnings Test Its Recovery Story
YahooXRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales
YahooHere's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings
YahooDENTSPLY SIRONA Inc. Q2 2026 Earnings Call Summary
YahooDENTSPLY SIRONA Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaDentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates
YahooDENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript
SeekingAlphaDentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations
YahooDentsply Sirona Reports Second Quarter 2026 Results
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$131.38B
BDXBecton, Dickinson and Company
$50.32B
MDLNMedline Inc.
$49.23B
ALCAlcon Inc.
$34.08B
RMDResMed Inc.
$32.94B
WSTWest Pharmaceutical Services, Inc.
$23.93B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B















